FundingHealthcare & Life Sciences
Foxo raises half million dollars in pre-seed funding
By Abha Lohia · Editor ·
Foxo: funding and every story →
pre-seed
- Foxo offers AI-driven personalized health support and wellness expert advice for high-stress executives
- The startup raised $0.5 Mn in a pre-seed round led by Blume Ventures in March 2025
- It targets founders and senior operators with annual fees of few lakhs INR for diagnostic services
What happened
- Foxo is a premium membership platform focused on health longevity and preventive care.
- The company raised $0.5 Mn in a pre-seed round completed in March 2025.
- Blume Ventures led the investment round for the Indian startup.
- Foxo provides an AI-driven personalized support system combined with direct access to wellness experts.
- The service uses a systems biology approach to analyze individual health data comprehensively.
- Clients receive an initial full diagnostic battery followed by quarterly biomarker tests.
- Weekly clinical consultations are included alongside continuous mobile app access for users.
- The platform claims 85-90% confidence in predicting severe lifestyle diseases like heart attacks or diabetes.
Why it matters
- The funding validates the growing market demand for proactive health management among high-net-worth individuals.
- Pre-seed capital allows Foxo to scale its AI infrastructure and expand its diagnostic capabilities.
- Investors likely see potential in targeting executives who can afford premium annual healthcare subscriptions.
The business
- Foxo operates a selective acceptance model based on client alignment with its health philosophy.
- The flagship membership tier requires an annual fee of a few lakhs INR.
- Pricing excludes costs for wearables, fitness memberships, and supplements sold separately.
- The ideal customer profile includes founders, operators, and senior executives with high-stress lives.
- These clients typically have the financial ability to pay for comprehensive annual health packages.
- Services focus on preventing chronic conditions through early detection and continuous monitoring.
- The business model relies on recurring revenue from long-term membership subscriptions.
- Data from diagnostics feeds into the AI system to refine future health predictions.
- Foxo competes globally with firms like Next Health and Lucis in the longevity space.
The founders
SP
Subhendu Panigrahi
Co-founder- He is a graduate of IIT-Kharagpur.
- Panigrahi previously founded Skillenza in 2014.
- His background combines technical expertise with entrepreneurial experience in professional networks.
AG
Akash Gehani
Co-founder- Gehani has spent 15 years focusing on personal health optimization.
- He maintains a history of avoiding medication through lifestyle interventions.
- His experience informs the company's preventive health strategy and product design.
SK
Sanmaya Kumar Dhal
Co-founder- Dhal possesses a strong techie background suitable for building AI systems.
- He holds a specific interest in applying healthcare AI to diagnostics.
- His role supports the technological infrastructure required for personalized health predictions.
Who put in money
- Blume Ventures lead — A venture capital firm investing in early-stage Indian startups.
In numbers
$0.5 MnFunding Amount · 2025
85-90%Prediction Confidence
Few lakhs INRAnnual Fee
Earlier rounds
- March 2025 · pre-seed · $0.5 Mn · led by Blume Ventures
Up against
Next HealthLucisBiopeak
Words to know
- Pre-seed
- The earliest stage of funding where a startup develops its initial product and team before seeking larger investments.
- Biomarker
- A measurable indicator of biological state used to assess health status or disease risk.
- Systems Biology
- An approach to biological research that focuses on complex interactions within biological systems rather than isolated parts.
The numbers around it
Healthcare & Life Sciences in March 2026: 16 rounds with a disclosed amount, $134 million in all; the biggest was Cult.fit (₹440 Cr ($47.2 Mn)). Every sector this year →
Terms in this story
- Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Foxo → · All startup news on 14 March 2026 →
Is this Foxo? Get your “Featured on StopDown” badge →